Shares of Vertex Pharmaceuticals Inc.
VRTX,
rallied 3.91% to $198.44 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index
SPX,
falling 0.71% to 4,448.08 and Dow Jones Industrial Average
DJIA,
falling 0.79% to 35,343.28. The stock’s rise snapped a seven-day losing streak. Vertex Pharmaceuticals Inc. closed $85.01 below its 52-week high ($283.45), which the company achieved on September 2nd.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson
JNJ,
rose 0.92% to $179.47, Merck & Co. Inc.
MRK,
rose 1.15% to $78.83, and AbbVie Inc.
ABBV,
rose 1.06% to $119.66. Trading volume (2.1 M) remained 612,998 below its 50-day average volume of 2.7 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Read More: Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day